NCT00150059View on ClinicalTrials.gov

Efficacy and Safety of Pimecrolimus Cream 1% in Patients ≥ 3 Months of Age With Mild or Moderate Atopic Dermatitis

PHASE4CompletedINTERVENTIONAL
Timeline

Start Date

December 31, 2004

Study Completion Date

December 31, 2005

Conditions
Atopic Dermatitis
Interventions
DRUG

Pimecrolimus Cream 1%

Trial Locations (1)

Unknown

This study is not being conducted in the United States, Investigative Site

Sponsors

Lead Sponsor

Novartis
All Listed Sponsors
lead

Novartis

INDUSTRY